用新的分子洞察力重新审视儿童脑瘤的治疗方法
1Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Cell
|February 27, 2016
概括
儿童中枢神经系统原始神经外皮脑瘤 (CNS-PNET) 是罕见的. 通过先进的分析确定了四个实体的新分子分类,为瘤学家提供了新的见解.
科学领域:
- 神经瘤学
- 分子生物学
- 基因组学
背景情况:
- 儿童中枢神经系统原始性神经外皮性脑瘤 (CNS-PNETs) 是一种罕见的不同类型的脑瘤.
- 中枢神经系统-PNET的生物特征和分类仍然不清楚,这阻碍了有效的治疗策略.
研究的目的:
- 研究儿童中枢神经网络的分子生物学.
- 为这些具有挑战性的瘤建立新的分子分类.
主要方法:
- 使用综合分子分析,包括先进的基因组和转录组分析.
- 应用最先进的方法来探究分子层面的瘤生物学.
主要成果:
- 在儿科中枢神经网络中确定了不同的分子子组.
- 提出了一个新的分子分类,包括基于综合分析的四个新实体.
结论:
- 拟议的分子分类为了解中枢神经系统-PNET提供了精细的框架.
- 这些发现对儿童神经瘤学的未来诊断,预后和治疗策略有重大影响.
更多相关视频
08:46A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
Published on: March 7, 2017
17.6K
04:01Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures
Published on: June 23, 2023
3.1K
相关概念视频
Treatment Resistent Cancers
1.5K
1.5K
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
